Plumbridge T W, Brown J R
Biochim Biophys Acta. 1979 Jun 20;563(1):181-92. doi: 10.1016/0005-2787(79)90019-4.
The reinforced intercalative binding to DNA typical of adriamycin and daunomycin can still occur if there is epimerisation at C4' or if the O-methyl group is lost or if the 9-substituents are deleted or if the 4'-hydroxyl group is lost. In the latter two cases however, there is a reduction in affinity for the DNA, supporting the suggested role of the 9-hydroxyl and 4'-hydroxyl groups in secondary stabilization of the complex. Epimerisation at C-1' or at C-3' alters but does not abolish the intercalative mode of binding to DNA whereas epimerisation at C-7 precludes intercalation of the chromophore into the helix of DNA. In contrast to the interaction with the B-form found in DNA, the parent drugs do not intercalate into nucleic acids possessing the A-conformation and none of the above-mentioned structural changes will allow intercalation into A-form nucleic acids.
如果在C4'处发生差向异构化,或者O-甲基丢失,或者9-取代基缺失,或者4'-羟基丢失,阿霉素和柔红霉素典型的与DNA的增强插入结合仍可能发生。然而,在后两种情况下,对DNA的亲和力会降低,这支持了9-羟基和4'-羟基在复合物二级稳定中的作用。C-1'或C-3'处的差向异构化会改变但不会消除与DNA的插入结合模式,而C-7处的差向异构化则会阻止发色团插入DNA螺旋。与在DNA中发现的与B型的相互作用不同,母体药物不会插入具有A构象的核酸中,上述任何结构变化都不会使其插入A型核酸中。